Trial Profile
A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2020
Price :
$35
*
At a glance
- Drugs ReN 001 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PISCES II
- Sponsors ReNeuron
- 18 Feb 2020 Results published in the ReNeuron Media Release.
- 18 Feb 2020 According to an ReNeuron media release, positive clinical data from this study was published online in the Journal of Neurology, Neurosurgery, and Psychiatry.
- 26 Jan 2018 Results presented at the International Stroke Conference 2018